Efficacy of Daratumumab, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma Patients with 1 to 3 Prior Lines of Therapy: Updated Analysis of Pollux

被引：5

作者：

Usmani, Saad Z. ^{[1
]}

Dimopoulos, Meletios A. ^{[2
]}

Belch, Andrew ^{[3
]}

White, Darrell ^{[4
]}

Benboubker, Lofti ^{[5
]}

Cook, Gordon ^{[6
,7
]}

Leiba, Merav ^{[8
]}

Morton, James ^{[9
]}

Ho, P. Joy ^{[10
]}

Kim, Kihyun ^{[11
]}

Takezako, Naoki ^{[12
]}

Khokhar, Nushmia Z. ^{[13
]}

Guckert, Mary ^{[13
]}

Wu, Kaida ^{[13
]}

Qin, Xiang ^{[13
]}

Casneuf, Tineke ^{[14
]}

Chiu, Christopher ^{[13
]}

Sasser, A. Kate ^{[13
]}

San-Miguel, Jesus ^{[15
]}

机构：

[1] Levine Canc Inst Carolinas HealthCare Syst, Charlotte, NC USA

[2] Univ Athens, Athens, Greece

[3] Univ Alberta Cross Canc Inst, Dept Oncol, Edmonton, AB, Canada

[4] Dalhousie Univ, QEII Hlth Sci Ctr, Halifax, NS, Canada

[5] Ctr Hosp Regional Univ CHRU, Serv Hematol & Therapie Cellulaire, Hop Bretonneau, Tours, France

[6] Leeds Teaching Hosp NHS Trust, St Jamess Inst Oncol, Leeds, W Yorkshire, England

[7] Univ Leeds, Leeds, W Yorkshire, England

[8] Sheba Med Ctr, Tel Hashomer, Israel

[9] Icon Canc Care, South Brisbane, Qld, Australia

[10] Royal Prince Alfred Hosp, Inst Haematol, Camperdown, NSW, Australia

[11] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Med, Seoul, South Korea

[12] Natl Hosp Org Disaster Med Ctr Japan, Dept Hematol, Tachikawa, Tokyo, Japan

[13] Janssen Res & Dev, LLC, Spring House, PA USA

[14] Janssen Res & Dev, Beerse, Belgium

[15] Clin Univ Navarra CIMA, IDISNA, Pamplona, Spain

来源：

BLOOD | 2016年 / 128卷 / 22期

关键词：

D O I：

10.1182/blood.V128.22.1151.1151

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1151

引用

页数：7

共 50 条

[21] Addition of daratumumab to the combination of lenalidomide and dexamethasone in relapsed or refractory myeloma
Stocker, Nicolas
HEMATOLOGIE, 2019, 25 (01): : 10 - 11
[22] Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment
David S. Siegel
Gary J. Schiller
Christy Samaras
Michael Sebag
Jesus Berdeja
Siddhartha Ganguly
Jeffrey Matous
Kevin Song
Christopher S. Seet
Giampaolo Talamo
Mirelis Acosta-Rivera
Michael Bar
Donald Quick
Bertrand Anz
Gustavo Fonseca
Donna Reece
William E. Pierceall
Weiyuan Chung
Faiza Zafar
Amit Agarwal
Nizar J. Bahlis
Leukemia, 2020, 34 : 3286 - 3297
[23] Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment
Siegel, David S.
Schiller, Gary J.
Samaras, Christy
Sebag, Michael
Berdeja, Jesus
Ganguly, Siddhartha
Matous, Jeffrey
Song, Kevin
Seet, Christopher S.
Talamo, Giampaolo
Acosta-Rivera, Mirelis
Bar, Michael
Quick, Donald
Anz, Bertrand
Fonseca, Gustavo
Reece, Donna
Pierceall, William E.
Chung, Weiyuan
Zafar, Faiza
Agarwal, Amit
Bahlis, Nizar J.
LEUKEMIA, 2020, 34 (12) : 3286 - 3297
[24] Preliminary Safety and Efficacy Data Of Daratumumab In Combination With Lenalidomide and Dexamethasone In Relapsed Or Refractory Multiple Myeloma
Plesner, Torben
Arkenau, Tobias
Lokhorst, Henk
Gimsing, Peter
Krejcik, Jakub
Lemech, Charlotte
Minnema, Monique C.
Lassen, Ulrik
Cakana, Andrew
Brun, Nikolai Constantin
Basse, Linda
Palumbo, Antonio
Richardson, Paul G.
BLOOD, 2013, 122 (21)
[25] Daratumumab, Lenalidomide and Dexamethasone (DRd) vs Lenalidomide and Dexamethasone (Rd) in RRMM Based on Prior Lines and Treatment Exposure: POLLUX
Dimopoulos, Meletios
Belch, Andrew R.
White, Darrell J.
Benboubker, Lofti
Cook, Gordon
Leiba, Merav
Morton, James
Ho, P. Joy
Kim, Kihyun
Takezako, Naoki
San-Miguel, Jesus
Moreau, Philippe
Kaufman, Jonathan L.
Sutherland, Heather
Lalancette, Marc
Magen, Hila
Iida, Shinsuke
Kim, Jin Seok
Prince, H. Miles
Cochrane, Tara
Oriol, Albert
Chari, Ajai
O'Rourke, Lisa
Wu, Kaida
Casneuf, Tineke
Chiu, Christopher
Soong, David
Qin, Xiang
Sasser, Kate
Khokhar, Nushmia
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E116 - E116
[26] Efficacy and safety of daratumumab, lenalidomide, and dexamethasone (D-Rd) in relapsed or refractory multiple myeloma (RRMM): Updated subgroup analysis of POLLUX based on cytogenetic risk.
Kaufman, Jonathan L.
Dimopoulos, Meletios A.
Leiba, Merav
Morton, James
Ho, P. Joy
Kim, Kihyun
Moreau, Philippe
Sutherland, Heather J.
Iida, Shinsuke
Kim, Jin Seok
Prince, H. Miles
Rocafiguera, Albert Oriol
Bahlis, Nizar J.
Chari, Ajai
Avet-Loiseau, Herve
Chiu, Christopher
Soong, David
Ukropec, Jon
Qi, Ming
San Miguel, Jesus
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[27] Efficacy of ixazomib, lenalidomide, dexamethasone regimen in daratumumab-exposed relapsed/refractory multiple myeloma patients: A retrospective analysis
Fric, Dominik
Stork, Martin
Boichuk, Ivanna
Sandecka, Viera
Adam, Zdenek
Krejci, Marta
Ondrouskova, Eva
Fidrichova, Anna
Radova, Lenka
Knechtova, Zdenka
Jarosova, Marie
Pour, Ludek
EUROPEAN JOURNAL OF HAEMATOLOGY, 2024,
[28] This abstract is part of the Presidential Symposium AN OPEN-LABEL, RANDOMISED, PHASE 3 STUDY OF DARATUMUMAB, LENALIDOMIDE, AND DEXAMETHASONE (DRD) VERSUS LENALIDOMIDE AND DEXAMETHASONE (RD) IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM): POLLUX
Dimopoulos, M. A.
Oriol, A.
Nahi, H.
Miguel, J. S.
Bahlis, N. J.
Rabin, N.
Orlowski, R.
Komarnicki, M.
Suzuki, K.
Plesner, T.
Samoilova, O. S.
Yoon, S. S.
Yehuda, D. B.
Richardson, P. G.
Goldschmidt, H.
Reece, D.
Khokhar, N.
O'Rourke, L.
Chiu, C.
Qin, X.
Guckert, M.
Ahmadi, T.
Moreau, P.
HAEMATOLOGICA, 2016, 101 : 342 - 342
[29] Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
Dimopoulos, Meletios
Spencer, Andrew
Attal, Michael
Prince, H. Miles
Harousseau, Jean-Luc
Dmoszynska, Anna
San Miguel, Jesus
Hellmann, Andrzej
Facon, Thierry
Foa, Robin
Corso, Alessandro
Masliak, Zvenyslava
Olesnyckyj, Marta
Yu, Zhinuan
Patin, John
Zeldis, Jerome B.
Knight, Robert D.
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21): : 2123 - 2132
[30] Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma
Dabkara, Deepak
Bajpai, Jyoti
INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2008, 29 (03) : 10 - 13

← 1 2 3 4 5 →